Canada markets close in 21 minutes

Myriad Genetics, Inc. (MYGN)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.45+0.19 (+0.99%)
As of 03:39PM EST. Market open.
Full screen
Trade prices are not sourced from all markets
Previous Close19.26
Open19.26
Bid19.50 x 800
Ask19.53 x 1000
Day's Range19.11 - 19.81
52 Week Range13.92 - 28.18
Volume341,481
Avg. Volume762,826
Market Cap1.576B
Beta (5Y Monthly)1.76
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateNov 01, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est19.56
  • Zacks

    Myriad Genetics (MYGN) Ailed by Mounting Costs, FX Headwind

    Myriad Genetics' (MYGN) significant gross margin contraction and operating loss as a result of mounting cost pressure are concerning.

  • GlobeNewswire

    Myriad Genetics Applauds New Guidelines Recommending Screening for Chromosomal Abnormalities

    Myriad Genetics continues to advance non-invasive prenatal screening with Prequel® and the forthcoming FirstGene™ test using AMPLIFY™ technology SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for a recent guideline update by the American College of Medical Genetics and Genomics (ACMG), reaffirming the clinical value of non-invasive prenatal screening (NIPS) for a range of chr

  • GlobeNewswire

    Myriad Genetics to Present at 41st Annual J.P. Morgan Healthcare Conference

    SALT LAKE CITY, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced Paul J. Diaz, president and chief executive officer, and Dale Muzzey, chief scientific officer, will present at the 41st Annual J.P. Morgan (JPM) Healthcare Conference on Monday, Jan. 9, 2023 at 4:30 p.m. PST/7:30 p.m. EST. The presentation will be available through a live webcast on the Myriad Genetics Investor Relations website. An archive